Recent ALLO News
- Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/16/2024 01:30:00 PM
- Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman • GlobeNewswire Inc. • 12/12/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2024 09:53:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/09/2024 09:02:39 PM
- Allogene Therapeutics Announces Participation in December Investor Conferences • GlobeNewswire Inc. • 11/19/2024 01:30:00 PM
- Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence • GlobeNewswire Inc. • 11/18/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 09:29:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:52 PM
- Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 11/07/2024 09:02:00 PM
- Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS • GlobeNewswire Inc. • 11/07/2024 03:00:00 PM
- Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidney Cancer Symposium (IKCS) and Society for Immunotherapy • GlobeNewswire Inc. • 11/05/2024 02:10:30 PM
- Allogene Therapeutics Announces Participation in November Investor Conferences • GlobeNewswire Inc. • 11/04/2024 01:30:00 PM
- Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update • GlobeNewswire Inc. • 10/30/2024 12:30:00 PM
- Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) • GlobeNewswire Inc. • 10/29/2024 12:30:00 PM
- Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors • GlobeNewswire Inc. • 10/22/2024 08:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/22/2024 07:24:03 PM
- Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference • GlobeNewswire Inc. • 09/30/2024 12:30:00 PM
- Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence • GlobeNewswire Inc. • 09/26/2024 12:30:00 PM
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:06:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:04:23 PM
- Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/07/2024 08:02:54 PM
- Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) • GlobeNewswire Inc. • 07/01/2024 12:30:00 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM